Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-11-26, Stock:JNJ, The news for the past five days is as follows:
2018-11-16: NEWS1: Notable Friday Option Activity: JNJ, PDFS, ULTI.NEWS2: Notable Friday Option Activity: JNJ, PDFS, ULTI.NEWS3: How Bausch + Lomb/International Performed.NEWS4: Baxter International: Why Investors Are Interested.NEWS5: Analyzing Baxter International’s Operational Performance.NEWS6: Health Care Sector Update for 11/16/2018: HCM, VLRX, AZN, JNJ, PFE, ABT, MRK, AMGN.NEWS7: Health Care Sector Update for 11/16/2018: HCM, VLRX, AZN, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for November 19, 2018.NEWS9: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for November 19, 2018.NEWS10: New jury fails to reach verdict in J&J South Carolina talc cancer trial.NEWS11: ACUVUE OASYS with Transitions Light Intelligent Technology Named Among TIME's 'Best Inventions of 2018'.
2018-11-19: NEWS1: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS2: Nasdaq Slides More Than 3% As These Dow Blue Chips Buck The Broad Sell-Off.NEWS3: Bulls Stampeded by Bears as FAANG Stocks Get Trampled.NEWS4: MorphoSys Says Janssen Initiates Phase 2 Study To Evaluate Guselkumab In HS.NEWS5: MorphoSys Says Janssen Initiates Phase 2 Study To Evaluate Guselkumab In HS.NEWS6: Pfizer, Other Pharma Stocks Should Continue to Do Well Amid Market Volatility.NEWS7: Pfizer's Oncology Offerings Present Opportunity for Long-Term Stock Growth.NEWS8: Notable ETF Inflow Detected - IWD, JPM, XOM, JNJ.NEWS9: Notable ETF Inflow Detected - IWD, JPM, XOM, JNJ.NEWS10: Dow Movers: AAPL, JNJ.NEWS11: Dow Movers: AAPL, JNJ.NEWS12: J&J Gets Positive CHMP Opinion for Prostate Cancer Treatment.NEWS13: J&J Gets Positive CHMP Opinion for Prostate Cancer Treatment.NEWS14: J&J Gets Positive CHMP Opinion for Prostate Cancer Treatment.NEWS15: Baxter International: Analysts Remain Bullish on the Stock.
2018-11-20: NEWS1: Dow Sinks 551 Points as Tech, Retail, Oil Sell Off.NEWS2: Dow Sinks 551 Points as Tech, Retail, Oil Sell Off.NEWS3: Market Close Report: NASDAQ Composite index closes at 6,908.82 down -119.66 points.NEWS4: Market Close Report: NASDAQ Composite index closes at 6,908.82 down -119.66 points.NEWS5: Glaxo Seeks Label Expansion of Nucala in Pediatric Patients.NEWS6: Merck’s Stock Price Has Increased ~34% in 2018.NEWS7: Here's What's Actually Working as the Market Sells Off: Charts.NEWS8: Dow Movers: BA, VZ.NEWS9: Dow Movers: BA, VZ.NEWS10: 5 Dow Stocks to Sell (And 2 to Buy).NEWS11: 5 Companies Hit 52-Week Highs.NEWS12: Health Care Sector Update for 11/20/2018: ORPN, BLRX, BSX, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Health Care Sector Update for 11/20/2018: ORPN, BLRX, BSX, JNJ, PFE, ABT, MRK, AMGN.NEWS14: The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings.NEWS15: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS16: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.
2018-11-21: NEWS1: Dow Surrenders Triple-Digit Lead; Tech Helps Nasdaq Higher.NEWS2: Dow Surrenders Triple-Digit Lead; Tech Helps Nasdaq Higher.NEWS3: Market Close Report: NASDAQ Composite index closes at 6,972.25 up 63.43 points.NEWS4: Market Close Report: NASDAQ Composite index closes at 6,972.25 up 63.43 points.NEWS5: Stock Market Rally Dampened As Dow Gives Up 200-Point Gain.NEWS6: Health Care Sector Update for 11/21/2018: BPMC,CYAD,SYN,JNJ.NEWS7: Health Care Sector Update for 11/21/2018: BPMC,CYAD,SYN,JNJ.NEWS8: U.S. appeals court declines J&J bid to stop generic Zytiga sales.NEWS9: Health Care Sector Update for 11/21/2018: CYAD,SYN,JNJ.NEWS10: Health Care Sector Update for 11/21/2018: CYAD,SYN,JNJ.NEWS11: 5 Top Stock Trades to Mull Over Thanksgiving.NEWS12: J&J Falls After Failing to Block Generic Zytiga Cancer Drug.NEWS13: Johnson & Johnson&apos;s stock drops to pace Dow decliners after appeals court ruling on Zytiga disappoints.NEWS14: Theravance JAK Inhibitor Enters Phase II for Crohn's Disease.NEWS15: Theravance JAK Inhibitor Enters Phase II for Crohn's Disease.NEWS16: Shire-Takeda Deal Gets Phase I Conditional European Approval.NEWS17: Shire-Takeda Deal Gets Phase I Conditional European Approval.NEWS18: Mylan Recalls Valsartan Lots, Gets FDA Warning for Facility.NEWS19: Mylan Recalls Valsartan Lots, Gets FDA Warning for Facility.NEWS20: Dow Movers: JNJ, CAT.NEWS21: Dow Movers: JNJ, CAT.NEWS22: S&P 500 Movers: JNJ, FL.NEWS23: S&P 500 Movers: JNJ, FL.NEWS24: Theravance JAK Inhibitor Enters Phase II for Crohn's Disease.NEWS25: Can Deal Interest Help Tesaro Recover?.NEWS26: Can Deal Interest Help Tesaro Recover?.NEWS27: Analysts Remain Bullish on Stryker Stock.NEWS28: Understanding Stryker’s Operational Performance.NEWS29: How Stryker Is Positioned in November.NEWS30: Mylan Recalls Valsartan Lots, Gets FDA Warning for Facility.NEWS31: Health Care Sector Update for 11/21/2018: SYN, CYAD, JNJ, PFE, ABT, MRK, AMGN.NEWS32: Health Care Sector Update for 11/21/2018: SYN, CYAD, JNJ, PFE, ABT, MRK, AMGN.NEWS33: Shire-Takeda Deal Gets Phase I Conditional European Approval.NEWS34: Can Deal Interest Help Tesaro Recover?.NEWS35: Today's Research Reports on Trending Tickers: Johnson & Johnson and Merck & Co..NEWS36: Capitalism Is Working in the U.S..
2018-11-23: NEWS1: Bayer Hurts from Generic Competition & Pipeline Setbacks.NEWS2: Bayer Hurts from Generic Competition & Pipeline Setbacks.NEWS3: Bayer Hurts from Generic Competition & Pipeline Setbacks.NEWS4: Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs.NEWS5: Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs.NEWS6: Dow 30 Stock Roundup: Boeing to Supply 40 737 MAX 8 to Jeju Air, Pfizer Gets FDA Nod.NEWS7: Dow 30 Stock Roundup: Boeing to Supply 40 737 MAX 8 to Jeju Air, Pfizer Gets FDA Nod.NEWS8: Gauging Analysts’ Views on Tesaro Stock.NEWS9: Understanding Tesaro’s Gross Margin Trend.NEWS10: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for November 26, 2018.NEWS11: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for November 26, 2018.NEWS12: Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs.NEWS13: Dow 30 Stock Roundup: Boeing to Supply 40 737 MAX 8 to Jeju Air, Pfizer Gets FDA Nod.NEWS14: Today's Research Reports on Trending Tickers: Altimmune and Johnson & Johnson.

Answer: Decrease